KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Interest Expenses (2016)

Historic Interest Expenses for AbbVie (ABBV) over the last 5 years, with Q2 2016 value amounting to $245.0 million.

  • AbbVie's Interest Expenses rose 4244.19% to $245.0 million in Q2 2016 from the same period last year, while for Mar 2017 it was $245.0 million, marking a year-over-year decrease of 6945.14%. This contributed to the annual value of $719.0 million for FY2015, which is 6759.91% up from last year.
  • Latest data reveals that AbbVie reported Interest Expenses of $245.0 million as of Q2 2016, which was up 4244.19% from $215.0 million recorded in Q1 2016.
  • In the past 5 years, AbbVie's Interest Expenses registered a high of $245.0 million during Q2 2016, and its lowest value of $10.0 million during Q3 2012.
  • Over the past 5 years, AbbVie's median Interest Expenses value was $113.0 million (recorded in 2012), while the average stood at $125.8 million.
  • Over the last 5 years, AbbVie's Interest Expenses had its largest YoY gain of 65000.0% in 2013, and its largest YoY loss of 2127.66% in 2013.
  • Quarter analysis of 5 years shows AbbVie's Interest Expenses stood at $94.0 million in 2012, then decreased by 21.28% to $74.0 million in 2013, then surged by 87.84% to $139.0 million in 2014, then skyrocketed by 49.64% to $208.0 million in 2015, then grew by 17.79% to $245.0 million in 2016.
  • Its Interest Expenses stands at $245.0 million for Q2 2016, versus $215.0 million for Q1 2016 and $208.0 million for Q4 2015.